Company Filing History:
1 out of 1 
1 out of 7 Years Active: 2017
Title: Roberta Amaziles Silva Leite: Innovator in Vaccine Development
Introduction
Roberta Amaziles Silva Leite is a prominent inventor based in Viçosa, Brazil. She has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for swine. Her innovative work focuses on combating diseases associated with porcine circovirus 2 (PCV-2).
Latest Patents
Roberta holds a patent for "Recombinant antigens of porcine circovirus 2 (PCV-2) for vaccine formulations, diagnostic kit and use thereof." This invention pertains to the preparation of recombinant antigens derived from the viral capsid of PCV-2. The process involves expression in a prokaryotic system, purification in monomer form, and recovery of virus-like particles (VLPs). These antigens are utilized in vaccine formulations and diagnostic kits, providing alternatives to commercially available vaccines. Additionally, the ELISA kit developed can assess the quality of both commercial and experimental vaccines against PCV-2.
Career Highlights
Roberta has worked with notable institutions such as the Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and the Universidade Federal de Viçosa. Her research has significantly impacted the field of veterinary immunization, particularly in swine breeding systems.
Collaborations
Roberta has collaborated with esteemed colleagues, including Márcia Rogéria de Almeida and Abelardo Silva Junior. These partnerships have enhanced her research and contributed to the advancement of vaccine development.
Conclusion
Roberta Amaziles Silva Leite is a trailblazer in the field of veterinary vaccine development. Her innovative work on PCV-2 antigens has the potential to improve animal health and welfare in swine breeding systems. Her contributions are invaluable to the scientific community and the agricultural industry.